Corp. Attys Back Drug Co. In FTC Privilege Fight At DC Circ.
Business and attorney advocacy groups urged the D.C. Circuit to deny the Federal Trade Commission's bid to force Boehringer Ingelheim to give up documents from a 2008 Aggrenox patent dispute, saying...To view the full article, register now.
Already a subscriber? Click here to view full article